Dr Vk Paul
-
{
- All
- News
- Videos
-
"Potential Scenario Vaccines May Get Ineffective If...": Covid Panel Chief
Amid concerns over the Omicron variant of coronavirus, Covid Task Force chief Dr VK Paul on Tuesday said India should have vaccine platforms that are "adaptable quickly" with changing nature of the variants.
-
Increased Vaccine Uptake Need Of Hour: NITI Aayog Amid Omicron Scare
The Centres priority is to fully vaccinate the adult population of the country against coronavirus, NITI Aayogs Member-Health Dr VK Paul said as the new variant Omicron has triggered a global alarm with several countries imposing fresh curbs.
-
Masks Will Stay Through 2022, Need Drug Against Covid: NITI Aayog Member
Dr VK Paul, the NITI Aayog Member for Health, said battling Covid will require a combination of vaccines, effective drugs, and disciplined social behaviour. He did not ruling out a third wave and cautioned against the risky festival lying ahead.
-
Looking Very Deeply Into Issue Of Vaccine Booster Dose: NITI Aayog Member
The national expert committee on COVID-19 vaccination has discussed the issue of giving booster vaccine dose and it is being looked into very deeply, NITI Aayog Member (Health) Dr VK Paul said on Tuesday.
-
Serosurvey Does Not Cover Granularity At State Level: NITI Aayog Member
Serosurveys cannot be extrapolated to estimate mortality rates of COVID-19 or undercounting of the number of coronavirus infections as they are not meant to cover granularity at the level of the state, NITI Aayog member (health) Dr VK Paul has said.
-
"In A Marathon, Not A 100-Metre Sprinter": Centre On Covid Vaccination
India is vaccinating, on average, 50 lakh individuals against Covid daily since June 21, the Centre said today. The number has increased since the drive's new phase phase kicked in on June 21, said Dr VK Paul, NITI Aayog member for health.
-
Must Prepare To Administer One Crore Vaccine Doses Per Day: NITI Aayog
India should prepare to administer one crore Covid jabs a day which will be possible in a few weeks with due preparation and the vaccination should be taken up to 73 lakh doses in the next three weeks, Niti Aayog Member (Health) Dr VK Paul said.
-
Children Get Covid, Must Ensure They Don't Become Part Of Chain: Centre
The Centre is now focused on ensuring that children do not become part of the chain spreading COVID-19, NITI Ayog member - Health, Dr VK Paul said today.
-
No Significant Shift In Age Distribution Of Covid Cases: NITI Ayog Member
There is no significant shift in the age distribution of COVID-19 cases in the second wave as compared to the first one, said Dr VK Paul, Member (Health) of the NITI Aayog, on Monday.
-
"Very Worried About Maharashtra, Don't Take Virus For Granted": Centre
The Centre is "very worried" about the upsurge in coronavirus cases in Maharashtra, NITI Aayog member Dr VK Paul said on Thursday, adding the virus cannot be taken for granted if the country has to remain Covid-free.
-
Covishield, Covaxin Safe, Side-Effects Negligible: NITI Aayog Member
Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health), NITI Aayog, said on Tuesday and noted that the two "are safest of the vaccines".
-
"Potential Scenario Vaccines May Get Ineffective If...": Covid Panel Chief
Amid concerns over the Omicron variant of coronavirus, Covid Task Force chief Dr VK Paul on Tuesday said India should have vaccine platforms that are "adaptable quickly" with changing nature of the variants.
-
Increased Vaccine Uptake Need Of Hour: NITI Aayog Amid Omicron Scare
The Centres priority is to fully vaccinate the adult population of the country against coronavirus, NITI Aayogs Member-Health Dr VK Paul said as the new variant Omicron has triggered a global alarm with several countries imposing fresh curbs.
-
Masks Will Stay Through 2022, Need Drug Against Covid: NITI Aayog Member
Dr VK Paul, the NITI Aayog Member for Health, said battling Covid will require a combination of vaccines, effective drugs, and disciplined social behaviour. He did not ruling out a third wave and cautioned against the risky festival lying ahead.
-
Looking Very Deeply Into Issue Of Vaccine Booster Dose: NITI Aayog Member
The national expert committee on COVID-19 vaccination has discussed the issue of giving booster vaccine dose and it is being looked into very deeply, NITI Aayog Member (Health) Dr VK Paul said on Tuesday.
-
Serosurvey Does Not Cover Granularity At State Level: NITI Aayog Member
Serosurveys cannot be extrapolated to estimate mortality rates of COVID-19 or undercounting of the number of coronavirus infections as they are not meant to cover granularity at the level of the state, NITI Aayog member (health) Dr VK Paul has said.
-
"In A Marathon, Not A 100-Metre Sprinter": Centre On Covid Vaccination
India is vaccinating, on average, 50 lakh individuals against Covid daily since June 21, the Centre said today. The number has increased since the drive's new phase phase kicked in on June 21, said Dr VK Paul, NITI Aayog member for health.
-
Must Prepare To Administer One Crore Vaccine Doses Per Day: NITI Aayog
India should prepare to administer one crore Covid jabs a day which will be possible in a few weeks with due preparation and the vaccination should be taken up to 73 lakh doses in the next three weeks, Niti Aayog Member (Health) Dr VK Paul said.
-
Children Get Covid, Must Ensure They Don't Become Part Of Chain: Centre
The Centre is now focused on ensuring that children do not become part of the chain spreading COVID-19, NITI Ayog member - Health, Dr VK Paul said today.
-
No Significant Shift In Age Distribution Of Covid Cases: NITI Ayog Member
There is no significant shift in the age distribution of COVID-19 cases in the second wave as compared to the first one, said Dr VK Paul, Member (Health) of the NITI Aayog, on Monday.
-
"Very Worried About Maharashtra, Don't Take Virus For Granted": Centre
The Centre is "very worried" about the upsurge in coronavirus cases in Maharashtra, NITI Aayog member Dr VK Paul said on Thursday, adding the virus cannot be taken for granted if the country has to remain Covid-free.
-
Covishield, Covaxin Safe, Side-Effects Negligible: NITI Aayog Member
Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation have been tested on thousands of people and side-effects are negligible, Dr VK Paul, Member (Health), NITI Aayog, said on Tuesday and noted that the two "are safest of the vaccines".
